Carlos Manlio Diaz Garcia
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurons | 7 | 2025 | 297 | 2.970 |
Why?
|
| Insulin-Secreting Cells | 8 | 2018 | 18 | 2.280 |
Why?
|
| Insulin | 7 | 2016 | 325 | 1.840 |
Why?
|
| Hippocampus | 4 | 2024 | 198 | 1.820 |
Why?
|
| Astrocytes | 2 | 2024 | 80 | 1.340 |
Why?
|
| Glucose | 4 | 2024 | 209 | 1.270 |
Why?
|
| Calcium | 4 | 2022 | 243 | 1.160 |
Why?
|
| Toxins, Biological | 3 | 2015 | 7 | 1.150 |
Why?
|
| Lactic Acid | 2 | 2018 | 94 | 1.070 |
Why?
|
| Biosensing Techniques | 4 | 2025 | 48 | 0.970 |
Why?
|
| Glycolysis | 5 | 2025 | 96 | 0.920 |
Why?
|
| Lactates | 2 | 2024 | 20 | 0.880 |
Why?
|
| Ion Channels | 3 | 2016 | 28 | 0.880 |
Why?
|
| Animals | 22 | 2025 | 10699 | 0.860 |
Why?
|
| Fluorometry | 1 | 2024 | 8 | 0.850 |
Why?
|
| Glycogen | 1 | 2024 | 23 | 0.840 |
Why?
|
| Mitochondria | 3 | 2025 | 408 | 0.830 |
Why?
|
| Brain | 4 | 2025 | 770 | 0.800 |
Why?
|
| Oxygen Consumption | 1 | 2024 | 190 | 0.790 |
Why?
|
| Embryonic Development | 1 | 2023 | 22 | 0.780 |
Why?
|
| Anthozoa | 2 | 2013 | 3 | 0.780 |
Why?
|
| Embryo, Mammalian | 1 | 2023 | 32 | 0.770 |
Why?
|
| Citric Acid Cycle | 1 | 2021 | 16 | 0.690 |
Why?
|
| Mice | 10 | 2025 | 4808 | 0.670 |
Why?
|
| Energy Metabolism | 4 | 2025 | 216 | 0.660 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2019 | 65 | 0.600 |
Why?
|
| NAD | 3 | 2023 | 104 | 0.520 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2015 | 28 | 0.450 |
Why?
|
| Drug Discovery | 1 | 2015 | 37 | 0.440 |
Why?
|
| TRPV Cation Channels | 1 | 2014 | 16 | 0.420 |
Why?
|
| Glyburide | 1 | 2013 | 4 | 0.410 |
Why?
|
| Marine Toxins | 1 | 2013 | 6 | 0.410 |
Why?
|
| Transient Receptor Potential Channels | 1 | 2013 | 8 | 0.410 |
Why?
|
| TRPM Cation Channels | 1 | 2013 | 9 | 0.400 |
Why?
|
| Metabolic Syndrome | 1 | 2014 | 80 | 0.390 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2013 | 51 | 0.380 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 110 | 0.380 |
Why?
|
| Nerve Tissue Proteins | 1 | 2013 | 154 | 0.370 |
Why?
|
| Hydrozoa | 1 | 2012 | 1 | 0.370 |
Why?
|
| Glucose Intolerance | 1 | 2011 | 24 | 0.360 |
Why?
|
| Calcium Channel Blockers | 1 | 2011 | 41 | 0.360 |
Why?
|
| Models, Biological | 1 | 2014 | 469 | 0.350 |
Why?
|
| Peptides | 1 | 2013 | 296 | 0.340 |
Why?
|
| Ion Channel Gating | 1 | 2010 | 20 | 0.340 |
Why?
|
| Humans | 12 | 2025 | 28884 | 0.290 |
Why?
|
| Rats | 5 | 2018 | 1588 | 0.270 |
Why?
|
| Cell Line | 2 | 2024 | 700 | 0.270 |
Why?
|
| Cell Survival | 3 | 2013 | 419 | 0.250 |
Why?
|
| Male | 6 | 2021 | 13934 | 0.250 |
Why?
|
| Signal Transduction | 1 | 2013 | 1469 | 0.240 |
Why?
|
| Citric Acid | 1 | 2025 | 5 | 0.240 |
Why?
|
| Cytosol | 2 | 2025 | 49 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 2 | 2021 | 1658 | 0.220 |
Why?
|
| Sodium | 2 | 2022 | 50 | 0.220 |
Why?
|
| Cell Death | 1 | 2024 | 119 | 0.210 |
Why?
|
| Hydrogen Peroxide | 1 | 2024 | 145 | 0.200 |
Why?
|
| Up-Regulation | 1 | 2024 | 247 | 0.200 |
Why?
|
| Pluripotent Stem Cells | 1 | 2023 | 8 | 0.200 |
Why?
|
| Electron Transport | 1 | 2023 | 31 | 0.200 |
Why?
|
| Biological Clocks | 1 | 2023 | 8 | 0.200 |
Why?
|
| Chromatography, Gel | 2 | 2013 | 38 | 0.190 |
Why?
|
| Protein Kinases | 1 | 2024 | 155 | 0.190 |
Why?
|
| In Vitro Techniques | 1 | 2023 | 242 | 0.190 |
Why?
|
| Molecular Weight | 2 | 2013 | 122 | 0.190 |
Why?
|
| Species Specificity | 1 | 2023 | 195 | 0.190 |
Why?
|
| Cells, Cultured | 3 | 2018 | 1022 | 0.190 |
Why?
|
| Rats, Wistar | 2 | 2012 | 153 | 0.180 |
Why?
|
| Oxidation-Reduction | 1 | 2023 | 381 | 0.180 |
Why?
|
| Pain | 1 | 2024 | 258 | 0.180 |
Why?
|
| Oxidative Phosphorylation | 1 | 2021 | 29 | 0.170 |
Why?
|
| NADP | 1 | 2021 | 39 | 0.170 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2020 | 20 | 0.160 |
Why?
|
| Cell Differentiation | 1 | 2023 | 427 | 0.160 |
Why?
|
| Thermus thermophilus | 1 | 2019 | 8 | 0.150 |
Why?
|
| Luminescent Proteins | 1 | 2019 | 26 | 0.150 |
Why?
|
| Genetic Vectors | 1 | 2019 | 118 | 0.150 |
Why?
|
| Time Factors | 1 | 2023 | 1613 | 0.140 |
Why?
|
| HEK293 Cells | 1 | 2019 | 202 | 0.140 |
Why?
|
| Diabetic Neuropathies | 1 | 2017 | 16 | 0.130 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 117 | 0.130 |
Why?
|
| Hormones | 1 | 2016 | 44 | 0.120 |
Why?
|
| Pharmaceutical Preparations | 1 | 2016 | 49 | 0.120 |
Why?
|
| Membrane Potentials | 2 | 2012 | 65 | 0.110 |
Why?
|
| Potassium Chloride | 1 | 2013 | 11 | 0.100 |
Why?
|
| Lethal Dose 50 | 1 | 2013 | 14 | 0.100 |
Why?
|
| Toxicity Tests | 1 | 2013 | 11 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2017 | 344 | 0.100 |
Why?
|
| Pancreas | 1 | 2014 | 63 | 0.100 |
Why?
|
| Female | 2 | 2021 | 15634 | 0.100 |
Why?
|
| Calcium Channels, L-Type | 1 | 2012 | 9 | 0.100 |
Why?
|
| Indians, North American | 1 | 2017 | 544 | 0.100 |
Why?
|
| Coloring Agents | 2 | 2022 | 37 | 0.090 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 64 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 63 | 0.090 |
Why?
|
| Chromatography, Reverse-Phase | 1 | 2012 | 10 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2013 | 612 | 0.090 |
Why?
|
| Hemolysis | 1 | 2012 | 51 | 0.090 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2011 | 72 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 585 | 0.090 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2011 | 169 | 0.090 |
Why?
|
| Mice, Knockout | 1 | 2013 | 874 | 0.080 |
Why?
|
| Adenosine Triphosphate | 2 | 2022 | 121 | 0.080 |
Why?
|
| Calcium Channels | 1 | 2025 | 34 | 0.060 |
Why?
|
| Sodium-Calcium Exchanger | 1 | 2022 | 21 | 0.050 |
Why?
|
| Microfluidics | 1 | 2022 | 16 | 0.050 |
Why?
|
| Nerve Growth Factor | 1 | 2017 | 15 | 0.030 |
Why?
|
| Mexico | 1 | 2017 | 92 | 0.030 |
Why?
|
| Interleukin-10 | 1 | 2017 | 74 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 292 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2017 | 198 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2017 | 995 | 0.030 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2012 | 20 | 0.020 |
Why?
|
| Heart Diseases | 1 | 2012 | 71 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2012 | 139 | 0.020 |
Why?
|